Here’s my 2c worth. These trials take a loooooong time. The participants are on their deathbeds and have severely compromised immune systems, so our drugs, that rely on utilising their immune systems, are struggling to gain traction. I understand the pay rates, if you pay peanuts, you get monkeys, to get “experts” costs money. The trials are progressing, albeit slower than anticipated, but to date, there’s been no bad news, but also not a lot of good news. I am shocked that no one thought of using the 4 people who are cancer free in the companies marketing, great suggestion whoever that was. They will be raised capital this year, I’d suspect early in Q3. I think they all know that come the next AGM, it could be very messy. Dr Glover had a bit of a laugh at a comment at the 2-3 years needed for the Azercell registration trial, I’ll need to rewatch to see what I can read into that, positive or negative. I’m glad Glover is still around, he obviously sees something worth pursuing. Might drop off these forums for a while, and forget about watching the daily share price fluctuations.
IMU Price at posting:
2.6¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)